Screen a formula for the EU market

What you will accomplish

You will run Formuley's EU market screening for a saved formula, inspect Annex and fragrance-allergen findings, and collect the source context a qualified safety assessor or regulatory reviewer needs. Formuley organizes and flags rule matches; it does not issue a Cosmetic Product Safety Report, approve release, or replace professional judgment.

Before you start

Confirm the formula identity, percentages, product category, intended application, target market, and launch timing. Review every raw material's INCI identity and supplier documentation. EU and other multi-market compliance checking is available on Pro and higher tiers; additional regions outside the core US and EU pair require Business or higher access. Maker access covers US-only checks.

Run the EU screening

1. Open the formula check. Go to /compliance/check/[formulaId] for the saved formula.
2. Select EU. Add other intended markets only when you also need their separate rule results.
3. Choose Draft guidance during development. Use this mode to find likely issues while evidence is still being assembled.
4. Choose Release review for a release candidate. Supply the requested product context and evidence so missing or ambiguous release inputs remain visible.
5. Run the check. Review the EU result, status, rule-source links, source version, and effective-date context returned for the formula.

Review Annex and use-condition findings

The EU screening compares stored ingredient identities and percentages with Formuley's current rule catalog for prohibited and restricted substances, colorants, preservatives, UV filters, and allergen disclosures. A result can be Pass, Warning, or Fail, but those states describe the screening result—not legal clearance.

1. Open every prohibited finding. Confirm the matched identity and source before changing the formula.
2. Review every restricted finding. Compare the formula percentage, coded limit, product category, application, and use conditions.
3. Inspect colorant, preservative, and UV-filter findings. Verify that the rule applies to the exact material, grade, purpose, and finished product.
4. Open the cited regulatory source. Confirm that the source version and effective date apply to the planned launch.
5. Record unresolved evidence gaps. Keep ambiguous identity, concentration, or use-condition decisions with the release review for human resolution.

Apply the expanded fragrance-allergen model

Formuley's current published EU catalog uses an 81-entry fragrance-allergen model. Its coded transition logic uses July 31, 2026 as the expanded-disclosure effective date for new products and July 31, 2028 as the existing-product transition end date. The screening threshold is 0.001% for leave-on products and 0.01% for rinse-off products.

1. Confirm leave-on or rinse-off use. The selected application determines the screening threshold.
2. Review each detected allergen. Trace the contribution back to the correct raw material and supplier disclosure.
3. Confirm product timing. Have a qualified regulatory reviewer verify whether the new-product or existing-product transition applies to the product.
4. Generate the intended declaration. Use EU + Allergens in the INCI workflow only after identities, contributions, application, and timing are verified.

The catalog and dates describe current Formuley rule behavior. They are not a substitute for checking the controlling regulation, amendments, official guidance, and product-specific facts at release.

Prepare the human release handoff

1. Resolve formula-level failures. Correct a confirmed prohibited use or concentration problem before treating the formula as a release candidate.
2. Attach current evidence. Keep supplier documents, identity support, test evidence, and market-specific decisions with the release record.
3. Send the record for qualified review. A qualified safety assessor prepares or approves the CPSR and makes the safety judgment.
4. Complete external obligations outside Formuley. Formuley does not submit to CPNP and does not create the required external notification.

Check your work

• EU was selected for the intended formula and application.
• Each Annex or use-condition finding has been traced to the correct ingredient identity and percentage.
• Fragrance-allergen results use the intended leave-on or rinse-off threshold and the correct transition timing.
• The source version and effective-date context have been verified against current official material.
• A qualified safety assessor or regulatory reviewer owns the final safety, notification, and release decision.

If something does not look right

• If an ingredient match is wrong, correct or verify the raw-material identity before rerunning the check.
• If a percentage or limit appears inconsistent, confirm concentration basis, formula totals, product category, and application.
• If Release review is blocked, supply the missing structured context or evidence instead of treating Draft guidance as approval.
• If the allergen transition is uncertain, stop the label handoff and obtain qualified regulatory review for the product's first-sale history.
• If a result says Pass but required safety or notification work is incomplete, keep the product unreleased; screening is not final authority.

Next steps

• Generate and verify the INCI declaration
• Build a label from reviewed release snapshots
• Run the US and MoCRA screening